121 related articles for article (PubMed ID: 16849587)
1. Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer.
Spruck C; Sun D; Fiegl H; Marth C; Mueller-Holzner E; Goebel G; Widschwendter M; Reed SI
Cancer Res; 2006 Jul; 66(14):7355-60. PubMed ID: 16849587
[TBL] [Abstract][Full Text] [Related]
2. Processing of cyclin E differs between normal and tumor breast cells.
Harwell RM; Porter DC; Danes C; Keyomarsi K
Cancer Res; 2000 Jan; 60(2):481-9. PubMed ID: 10667604
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
[TBL] [Abstract][Full Text] [Related]
4. Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain.
Wang XD; Rosales JL; Magliocco A; Gnanakumar R; Lee KY
Oncogene; 2003 Feb; 22(5):769-74. PubMed ID: 12569370
[TBL] [Abstract][Full Text] [Related]
5. A study of the expression of Cyclin E and its isoforms in tumor and adjacent mucosa, correlated to patient outcome in early colon cancer.
Corin I; Larsson L; Bergström J; Gustavsson B; Derwinger K
Acta Oncol; 2010; 49(1):63-9. PubMed ID: 20001501
[TBL] [Abstract][Full Text] [Related]
6. Small interference RNA-mediated suppression of overexpressed cyclin E protein restores G1/S regulation in NIH-OVCAR-3 ovarian cancer cells.
Todd MC; Spruill SC; Meerbrey KL
Int J Oncol; 2009 Aug; 35(2):375-80. PubMed ID: 19578752
[TBL] [Abstract][Full Text] [Related]
7. Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype.
Libertini SJ; Robinson BS; Dhillon NK; Glick D; George M; Dandekar S; Gregg JP; Sawai E; Mudryj M
Cancer Res; 2005 Dec; 65(23):10700-8. PubMed ID: 16322214
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of cyclin E isoforms correlates with poor prognosis in rectal cancer.
Zhou YJ; Xie YT; Gu J; Yan L; Guan GX; Liu X
Eur J Surg Oncol; 2011 Dec; 37(12):1078-84. PubMed ID: 21944050
[TBL] [Abstract][Full Text] [Related]
9. Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival.
Milne AN; Carvalho R; Jansen M; Kranenbarg EK; van de Velde CJ; Morsink FM; Musler AR; Weterman MA; Offerhaus GJ
J Clin Pathol; 2008 Mar; 61(3):311-6. PubMed ID: 18305181
[TBL] [Abstract][Full Text] [Related]
10. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
Voduc D; Nielsen TO; Cheang MC; Foulkes WD
Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of cyclin E in low-risk node negative breast cancer.
Ahlin C; Gruhne B; Holmqvist M; Zetterberg A; Fjällskog ML
Acta Oncol; 2008; 47(8):1539-45. PubMed ID: 18607847
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of cyclin E expression in operable breast cancer.
Potemski P; Kusińska R; Pasz-Walczak G; Piekarski JH; Watała C; Płuciennik E; Bednarek AK; Kordek R
Med Sci Monit; 2009 Feb; 15(2):MT34-40. PubMed ID: 19179977
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
Li H; Weinstein IB
Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
[TBL] [Abstract][Full Text] [Related]
14. Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis.
Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
Hum Pathol; 2006 Dec; 37(12):1568-76. PubMed ID: 16949911
[TBL] [Abstract][Full Text] [Related]
15. The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo.
Bales E; Mills L; Milam N; McGahren-Murray M; Bandyopadhyay D; Chen D; Reed JA; Timchenko N; van den Oord JJ; Bar-Eli M; Keyomarsi K; Medrano EE
Cancer Res; 2005 Feb; 65(3):692-7. PubMed ID: 15705861
[TBL] [Abstract][Full Text] [Related]
16. HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells.
Guo X; Hartley RS
Cancer Res; 2006 Aug; 66(16):7948-56. PubMed ID: 16912169
[TBL] [Abstract][Full Text] [Related]
17. Why are the truncated cyclin Es more effective CDK2 activators than the full-length isoforms?
Rath SL; Senapati S
Biochemistry; 2014 Jul; 53(28):4612-24. PubMed ID: 24947816
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of cyclin E2 expression and associated kinase activity in primary breast tumors.
Payton M; Scully S; Chung G; Coats S
Oncogene; 2002 Dec; 21(55):8529-34. PubMed ID: 12466974
[TBL] [Abstract][Full Text] [Related]
19. Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers.
Berglund P; Stighall M; Jirström K; Borgquist S; Sjölander A; Hedenfalk I; Landberg G
Cancer Res; 2005 Nov; 65(21):9727-34. PubMed ID: 16266993
[TBL] [Abstract][Full Text] [Related]
20. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
Grabowski P; Schrader J; Wagner J; Hörsch D; Arnold R; Arnold CN; Georgieva I; Stein H; Zeitz M; Daniel PT; Sturm I
Clin Cancer Res; 2008 Nov; 14(22):7378-84. PubMed ID: 19010853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
